Skip to content
Screener

Strata Critical Medical SRTA Q2 2026 earnings

Reported August 4, 2026 · Before market open

Revenue$72.5MBeat by $4.9M
EPS-$0.12Miss by $0.10
Revenue estimate$67.6M
EPS estimate-$0.02
“Our strategic expansion into clinical services is running well ahead of schedule after our accelerated progress on both organic growth and M&A execution in Q2. Year-to-date, we've completed three acquisitions that have significantly expanded our footprint and operational efficiency while adding more than $6 million of projected annualized Adjusted EBITDA at our targeted mid-single-digit acquisition multiples.”
Will Heyburn

Next report

Nov 9, 2026 (In 3 weeks)
Revenue estimate$72.7M
EPS estimate$0.01

Valuation & ratios

Valuation

as of 10/12/26
See full
Market cap$395.45M-4.3%
Enterprise value$340.93M-13.3%
P/E7.6×—
P/S1.6×-0.6×

FAQ

When did Strata Critical Medical report Q2 2026 earnings?
Strata Critical Medical (SRTA) reported Q2 2026 earnings on August 4, 2026 before market open.
What were Strata Critical Medical's Q2 2026 revenue and EPS?
Strata Critical Medical reported revenue of $72.5M and eps of $-0.12 for Q2 2026.
Did Strata Critical Medical beat estimates in Q2 2026?
Revenue beat the consensus estimate of $67.6M by $4.9M. EPS missed the consensus estimate of $-0.02 by $0.10.
How did Strata Critical Medical's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.4% from $70.8M a year earlier and eps declined 140.0% from $-0.05.
Where can I find Strata Critical Medical's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-052152) and the 10-Q periodic report (0001628280-26-052256) directly on SEC EDGAR. The filing index links above go to sec.gov.